@Article{Latacz2021,
journal="Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej",
issn="1734-9338",
volume="17",
number="3",
year="2021",
title="Endovascular therapy of symptomatic high-grade stenosis of left internal carotid artery in C6 segment using Elutax “3” Neuro pDEB",
abstract="Intracranial atherosclerotic disease (ICAD) is a well-known cause of stroke and is responsible for approximately 5–10% of all strokes [1]. The annual risk of recurrent stroke in symptomatic ICAD is around 9–12% despite optimal medical treatment [2]. Patients presenting with symptomatic ICAD have been managed endovascularly (ET) for over two decades. Still, although initial results of such treatment were encouraging, the rates of periprocedural complications and restenoses were high, 15% and 34%, respectively [2].",
author="Latacz, Paweł
and Popiela, Tadeusz
and Brzegowy, Paweł
and Kwinta, Borys
and Chwała, Maciej
and Simka, Marian",
pages="332--333",
doi="10.5114/aic.2021.109162",
url="http://dx.doi.org/10.5114/aic.2021.109162"
}